PDF herunterladen
Dtsch Med Wochenschr 2012; 137(49): 2571-2573
DOI: 10.1055/s-0032-1327324
Pneumologie | Commentary
Pneumologie, Infektiologie
© Georg Thieme Verlag KG Stuttgart · New York

Nosokomiale Pneumonie

Neues aus der LeitlinieHospital-acquired pneumoniaNews from the guidelines
K. Dalhoff
1   Medizinische Klinik III – Pneumologie / Infektiologie, Universitätsklinikum Schleswig-Holstein
,
J. Lorenz
2   Klinik für Pneumologie und Internistische Intensivmedizin (Infektiologie, Schlafmedizin), Klinikum Lüdenscheid
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
19. November 2012 (online)

Auch verfügbar auf
    Lizenzen und Reprints

Schlüsselwörter

nosokomiale Pneumonie - HAP - S3-Leitlinie

Keywords

hospital-acquired pneumonia - HAP - German guideline
 

  • Literatur

  • 1 Aarts MA, Hancock JN, Heyland D et al. Empiric antibiotic therapy for suspected ventilator-associated pneumonia. Crit Care Med 2008; 36: 108-117
    CrossrefPubMedGoogle Scholar
  • 2 Brunkhorst FM, Oppert M, Marx G et al. Effect of empirical treatment with moxifloxacin and meropenem vs meropenem on sepsis-related organ dysfunction in patients with severe sepsis. JAMA 2012; 307: 2390-2399
    CrossrefPubMedGoogle Scholar
  • 3 Canadian Critical Care Trials Group. A randomized trial of diagnostic techniques for ventilator-associated pneumonia. N Engl J Med 2006; 355: 2619-2630
    CrossrefPubMedGoogle Scholar
  • 4 Chastre J, Wolff M, Fagon JY et al. Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults. JAMA 2003; 290: 2588-2598
    CrossrefPubMedGoogle Scholar
  • 5 Dalhoff K, Abele-Horn M, Andreas S et al. Epidemiologie, Diagnostik und Therapie erwachsener Patienten mit nosokomialer Pneumonie. Pneumologie 2012; 66 im Druck
    PubMedGoogle Scholar
  • 6 de Lassence A, Joly-Guillou ML, Salah A et al. Accuracy of delayed (24 hours) processing of bronchoalveolar lavage for diagnosing bacterial pneumonia. Crit Care Med 2004; 32: 680-685
    CrossrefPubMedGoogle Scholar
  • 7 Ewig S, Welte T, Chastre J et al. Rethinking the concepts of community-acquired and health-care-associated pneumonia. Lancet Infect Dis 2010; 10: 279-287
    CrossrefPubMedGoogle Scholar
  • 8 Garnacho-Montero J, Sa-Borges M, Sole-Violan J et al. Optimal management therapy for Pseudomonas aeruginosa ventilator-associated pneumonia: an observational, multicenter study comparing monotherapy with combination antibiotic therapy. Crit Care Med 2007; 35: 1888-1895
    CrossrefPubMedGoogle Scholar
  • 9 Heyland DK, Dodek P, Muscedere J et al. Randomized trial of combination versus monotherapy for the empiric treatment of suspected ventilator-associated pneumonia. Crit Care Med 2008; 36: 737-744
    CrossrefPubMedGoogle Scholar
  • 10 Kumar A, Roberts D, Wood KE et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 2006; 34: 1589-1596
    CrossrefPubMedGoogle Scholar
  • 11 Meersseman W, Lagrou K, Maertens J et al. Galactomannan in bronchoalveolar lavage fluid: a tool for diagnosing aspergillosis in intensive care unit patients. Am J Respir Crit Care Med 2008; 177: 27-34
    CrossrefPubMedGoogle Scholar
  • 12 Nationales Referenzzentrum für Surveillance von nosokomialen Infektionen. KISS (Krankenhaus-Infektions-Surveillance-System). www.nrz-hygiene.de/surveillance/kiss
    PubMedGoogle Scholar